Impact of repeated nasal sampling on detection and quantification of SARS-CoV-2
Abstract The impact of repeated sample collection on COVID-19 test performance is unknown. The FDA and CDC currently recommend the primary collection of diagnostic samples to minimize the perceived risk of false-negative findings. We therefore evaluated the association between repeated sample collec...
Saved in:
Main Authors: | Joshua M. Levy, Jennifer K. Frediani, Erika A. Tyburski, Anna Wood, Janet Figueroa, Russell R. Kempker, Paulina A. Rebolledo, Mark D. Gonzalez, Julie Sullivan, Miriam B. Vos, Jared O’Neal, Greg S. Martin, Wilbur A. Lam, Jesse J. Waggoner |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/39dfb0e9ecc74fe6a6c372c4079c88bd |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multidisciplinary assessment of the Abbott BinaxNOW SARS-CoV-2 point-of-care antigen test in the context of emerging viral variants and self-administration
by: Jennifer K. Frediani, et al.
Published: (2021) -
In Vitro Ciliotoxicity and Cytotoxicity Testing of Repeated Chronic Exposure to Topical Nasal Formulations for Safety Studies
by: Larisa Tratnjek, et al.
Published: (2021) -
Automated quantification of bioluminescence images
by: Alexander D. Klose, et al.
Published: (2018) -
Pilomatrixoma nasal: Nasal pilomatricoma
by: Inzunza P,Fernando, et al.
Published: (2009) -
The British Virgin Islands national integrated development strategy
by: O'Neal, Otto
Published: (2014)